Vaccine Development Insights

Dan discusses the evolution of vaccine technology, highlighting the collaborative efforts with Johnson & Johnson that have spanned over a decade. He emphasizes the promising results from the Zika vaccine trials and the potential benefits of a single-shot COVID vaccine, which could simplify logistics and improve accessibility. The ongoing monitoring of immune responses suggests durability that may extend beyond a year, offering hope for effective long-term protection.